Command Palette

Search for a command to run...

Clinical Trials · NCT02621489

Effects on Re-endothelialisation With Bydureon Treatment in Type 2 Diabetes Subjects

CompletedPhase 4Exenatide (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
Karolinska Institutet
Enrollment
38
Start date
Dec 2015
Locations
1 site, Sweden
Primary endpoint
The degree of non-covered stent struts by Bydureon add on to Insulin over that of Insulin as analyzed by optical coherence tomography (OCT).
View Exenatide compound reference